We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBK:KSENational Bank of Kuwait K.S.C. Analysis

Data as of 2026-05-29 - not real-time

$19.22

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at a price‑to‑book ratio of 0.33, indicating a deep discount relative to its book value, while delivering an impressive dividend yield of 6.62%. Technicals show the market is extremely overbought, with the RSI at 96.6 and a bearish MACD histogram, suggesting short‑term pressure despite a neutral trend. Fundamentals remain solid: revenue grew 18.3% YoY, operating margins sit near 45.7% and profit margins around 32.9%, supported by a massive cash pile that dwarfs debt. Volatility over the past 30 days is modest at roughly 15% and the computed beta is near zero, pointing to limited market‑wide price swings. However, trading volume is very low, raising concerns about liquidity on the KSE. Overall, the combination of a strong dividend, undervalued valuation metrics, and robust earnings capacity paints a favorable picture for patient investors.
In the near term, the overbought technicals and bearish MACD temper enthusiasm, but the long‑run fundamentals—high margins, solid cash generation, and a low P/B—suggest the stock is poised for a correction upward. Investors should weigh the liquidity constraints against the attractive yield and value upside, positioning the stock as a potential buy for medium to long horizons while remaining cautious in the short run.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating extreme overbought conditions
  • Bearish MACD histogram signaling short‑term downside
  • Low trading volume increasing liquidity risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued price‑to‑book ratio
  • Strong revenue growth and high operating margins
  • Attractive dividend yield with solid cash coverage

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by large cash reserves
  • Consistently high profitability metrics
  • Value‑oriented valuation offering upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth18.30%
Profit Margin32.89%
P/B Ratio0.3
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI96.6
Support$19.22
Resistance$19.22
MA 20$19.22
MA 50$19.20
MA 200$19.20
MACDBearish
VolumeStable
Fear & Greed Index93.13

Valuation

GradeUndervalued
TypeValue
Dividend Yield6.62%

Risk Assessment

Beta-0.01
Volatility0.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.